What trade war?: Western and Chinese life science companies just get on with it

The winter of discontent?: Britain's winter Brexit election

Seriously? Already?: Shawview Consulting two years on

Is your attitude worth catching?

Biopharmaceutical industry comes through in dealing with Ebola

History Repeats with the Release of the 2019 WHO Essential Medicines List

Australia's National Medicines Policy is outdated and in need of review

HTA 2.0: time for a reboot

Five generations in the workplace: a moment in history

UHC and medicine price transparency feature at 2019 World Health Assembly

Shooting For the Stars: The Evolution in Outcome-Based Payment Models for Medicines

A minor issue?: minor parties and independents in the 2019 Australian election

Reflections on the art of political campaigning and advocacy

Should I Stay or Should I Go?: Brexit the Musical

Alzheimer's failure a lesson in why pharma companies are vital

How do we turn the tide?: Winning the measles vaccination debate

The WHO’s Essential Medicines List: Changing the Conversation

"We need to talk about pharma profits"

The elites vs the rest: can trust barometers predict political disruption?

Be careful what you wish for: cancer innovation and drug pricing